The Pharmacology Graduate Training Program's mission is to prepare PhD
scientists in fields of pharmacology for careers in academic and industrial research,
governmental agencies and a variety of professional paths Our mission is accomplished
by training our Ph.D. students to be critical thinkers, embracing innovation and creativity
to advance scholarship and scientific discovery. This training program is the only one at
the University of Pennsylvania that trains predoctoral graduate students in fundamentals
of Pharmacology. Current areas of research and training in the PGG are
Neuropharmacology, Cell Signaling, Pharmacological Chemistry, Cancer Pharmacology,
Cardiovascular Pharmacology, Pharmacogenetics, Environmental Toxicology, and
Translational Medicine. The PGG offers 14 graduate-level courses in Pharmacology and
two recently developed workshops on “Professional Skills” and “Grant Writing/Candidacy
Exam” preparation. Over the past five years the total number of students in the program
has remained relatively constant with the current census at 68 (64 TGE) and the
number of faculty trainers has remained near 60. Due to the training requirements
associated with the training program, all predoctoral trainees supported by the training
grant are in the PGG. We request support for 12 predoctoral training positions for the
next 5 years. The pool of students available for appointment to the training program
comprises all US residents or students with permanent resident status in the PGG. We
support students for one to two years in Year 2 and 3 as most coursework and training
workshops occurs during these years however all students supported with this training
program continue to participate and enjoy the training related activities until awarding of
their PhD.
Public Health Relevance Statement
The Pharmacology Graduate Training Program at the University of Pennsylvania
is in its 33rd year, and over this time has produced 229 well-trained pharmacologists,
who have made an impact in academia, pharmaceutical and biotechnology industries,
regulatory agencies, and many other research related careers. The urgency to apply
basic discoveries to the understanding and alleviation of human disease has never been
greater. Thus, a major focus of our training program is on translational research, which
is in many ways the essence of pharmacology
No Sub Projects information available for 5T32GM008076-39
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32GM008076-39
Patents
No Patents information available for 5T32GM008076-39
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32GM008076-39
Clinical Studies
No Clinical Studies information available for 5T32GM008076-39
News and More
Related News Releases
No news release information available for 5T32GM008076-39
History
No Historical information available for 5T32GM008076-39
Similar Projects
No Similar Projects information available for 5T32GM008076-39